Head-to-head · WeighScore
MyDrHank vs No BS RX
By GLP-1 ScorecardUpdated
Score comparison
No BS RX has the higher recorded score — 82.8/100 to 68.2/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MyDrHank | No BS RX |
|---|---|---|
| WeighScore | 68.2/100 | 82.8/100 |
| Grade | C | B− |
| Site position | #106 | #25 |
| Semaglutide | From $171/mo oral or injectable on GLP-1 lander; injection product page from $178/mo (conflicting offer terms; confirm) | $179/mo month-to-month (a separate low-dose program is $140) |
| Tirzepatide | From $200/mo on GLP-1 lander; product page from $240/mo (conflicting offer terms; confirm) | $249/mo month-to-month (a separate low-dose program is $140) |
| Coverage | Confirm prescription and state; contiguous-U.S. shipping claim does not establish individual eligibility | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #106 · C
Strengths
- Public landing and product pages show starting prices before medical intake
- Compounded injection options and a separate oral semaglutide menu are advertised, with formulation differences to discuss with the prescriber
- Product pages advertise consultation, delivery, check-ins and unlimited clinical messaging; response times were not tested
- Terms identify the platform operator and offer the current pharmacy-partner list on request
What to consider
- The GLP-1 lander shows $171/$200 injectable starting rates, while separate injection pages show $178/$240; applicable purchase terms remain unresolved
- Published base plan fields do not establish that a particular promotion is unavailable or what an individual will actually pay
- The reviewed GLP-1 terms did not establish the cancellation cutoff, unused-prepayment refund formula or declined-treatment financial outcome
- The assigned medical practice, prescriber and dispensing location remain unestablished; no current individual license verification is claimed
- Dose, concentration, usable supply, laboratory costs and state-specific availability require confirmation
- Compounded preparations are not FDA-approved; displayed branded-product trial results do not establish outcomes for these formulations
Site position #25 · B−
Strengths
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
- Six programs across four terms are published with no intake and no account
- A sleep program is priced on the same page, including a diagnostic ring study at $33/mo
What to consider
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
- The Terms name four pharmacies and no operating company
- State availability is not published, and there is no FDA-approved brand lane
Featured provider
MyDrHank
MyDrHank scores 68.2/100 (C). MyDrHank advertises compounded tablets and injections, but its GLP-1 landing page and separate product pages show different starting prices; get one written offer before choosing a term.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.